ClinicalThought

HIV Annual Update: HIV Care in 2022 and Beyond

Watch the discussion and download slides from this engaging symposium reviewing the most important clinical developments in HIV management from the past year. Topics covered include evolving options for first-line ART and switch strategies for virologically suppressed patients, optimized regimens for patients with extensive treatment experience, new and expanding options for HIV prevention, the latest data and guidance on weight gain with ART, future innovations in HIV management, mitigating the effects of the COVID-19 pandemic on HIV care, and addressing racial inequities across the healthcare system.

Karine Lacombe, MD, PhD

Babafemi Taiwo, MBBS

ClinicalThought

2-Drug ART Regimens: Is a Simplified Regimen on the Horizon for Most Patients With HIV?

View ClinicalThought

My take on how 2-drug regimens and investigational agents are expanding our options for successful antiretroviral therapy in treatment-naive patients, virally suppressed patients switching regimens, and potentially to patients experiencing virologic failure.

Babafemi Taiwo, MBBS Released: November 5, 2021

ClinicalThought

Where Might Investigational Long-Acting 2-Drug Combinations of ARVs With Novel Mechanisms of Action Fit Into the Future HIV Treatment Landscape?

View ClinicalThought

Thoughts on how investigational, long-acting 2-drug regimens involving drugs with novel mechanisms of action may expand treatment options not only for treatment-experienced patients, but also for ART-naive patients in key populations with specific needs.

Karine Lacombe, MD, PhD Released: November 30, 2021

HIV Annual Update: HIV Care in 2022 and Beyond

2-Drug ART Regimens: Is a Simplified Regimen on the Horizon for Most Patients With HIV?

Where Might Investigational Long-Acting 2-Drug Combinations of ARVs With Novel Mechanisms of Action Fit Into the Future HIV Treatment Landscape?

Leaving the CCO site